Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: Q4QG93
Term | Name | Level | Count |
---|---|---|---|
GO:0006040 | amino sugar metabolic process | 4 | 7 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | 4 | 7 |
GO:0006048 | UDP-N-acetylglucosamine biosynthetic process | 5 | 7 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006793 | phosphorus metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009058 | biosynthetic process | 2 | 7 |
GO:0009225 | nucleotide-sugar metabolic process | 4 | 7 |
GO:0009226 | nucleotide-sugar biosynthetic process | 5 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0018130 | heterocycle biosynthetic process | 4 | 7 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0044249 | cellular biosynthetic process | 3 | 7 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 7 |
GO:0044281 | small molecule metabolic process | 2 | 7 |
GO:0046349 | amino sugar biosynthetic process | 5 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 7 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 7 |
GO:1901576 | organic substance biosynthetic process | 3 | 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 7 |
GO:0004343 | glucosamine 6-phosphate N-acetyltransferase activity | 7 | 7 |
GO:0008080 | N-acetyltransferase activity | 6 | 7 |
GO:0016407 | acetyltransferase activity | 5 | 7 |
GO:0016410 | N-acyltransferase activity | 5 | 7 |
GO:0016740 | transferase activity | 2 | 7 |
GO:0016746 | acyltransferase activity | 3 | 7 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.626 |
CLV_NRD_NRD_1 | 177 | 179 | PF00675 | 0.499 |
CLV_PCSK_FUR_1 | 175 | 179 | PF00082 | 0.480 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.648 |
CLV_PCSK_KEX2_1 | 177 | 179 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 116 | 120 | PF00082 | 0.532 |
CLV_PCSK_SKI1_1 | 164 | 168 | PF00082 | 0.550 |
CLV_PCSK_SKI1_1 | 222 | 226 | PF00082 | 0.438 |
CLV_PCSK_SKI1_1 | 228 | 232 | PF00082 | 0.382 |
CLV_PCSK_SKI1_1 | 42 | 46 | PF00082 | 0.513 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.464 |
DOC_MAPK_gen_1 | 250 | 258 | PF00069 | 0.436 |
DOC_MAPK_MEF2A_6 | 253 | 260 | PF00069 | 0.355 |
DOC_MAPK_NFAT4_5 | 253 | 261 | PF00069 | 0.319 |
DOC_PP2B_LxvP_1 | 258 | 261 | PF13499 | 0.397 |
DOC_PP4_FxxP_1 | 79 | 82 | PF00568 | 0.587 |
DOC_USP7_MATH_1 | 154 | 158 | PF00917 | 0.598 |
DOC_USP7_MATH_1 | 36 | 40 | PF00917 | 0.478 |
DOC_USP7_MATH_1 | 5 | 9 | PF00917 | 0.559 |
DOC_WW_Pin1_4 | 245 | 250 | PF00397 | 0.473 |
LIG_14-3-3_CanoR_1 | 164 | 169 | PF00244 | 0.585 |
LIG_14-3-3_CanoR_1 | 228 | 234 | PF00244 | 0.424 |
LIG_Actin_WH2_2 | 104 | 121 | PF00022 | 0.502 |
LIG_APCC_ABBA_1 | 70 | 75 | PF00400 | 0.539 |
LIG_APCC_ABBAyCdc20_2 | 69 | 75 | PF00400 | 0.483 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.686 |
LIG_BRCT_BRCA1_1 | 237 | 241 | PF00533 | 0.513 |
LIG_eIF4E_1 | 163 | 169 | PF01652 | 0.534 |
LIG_eIF4E_1 | 98 | 104 | PF01652 | 0.451 |
LIG_FHA_1 | 171 | 177 | PF00498 | 0.361 |
LIG_FHA_1 | 187 | 193 | PF00498 | 0.280 |
LIG_FHA_2 | 246 | 252 | PF00498 | 0.482 |
LIG_GBD_Chelix_1 | 95 | 103 | PF00786 | 0.468 |
LIG_LIR_Apic_2 | 76 | 82 | PF02991 | 0.590 |
LIG_LIR_Gen_1 | 22 | 31 | PF02991 | 0.515 |
LIG_LIR_Gen_1 | 232 | 241 | PF02991 | 0.417 |
LIG_LIR_Gen_1 | 46 | 55 | PF02991 | 0.587 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.517 |
LIG_LIR_Nem_3 | 232 | 236 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 43 | 48 | PF02991 | 0.486 |
LIG_LIR_Nem_3 | 86 | 91 | PF02991 | 0.475 |
LIG_Pex14_1 | 229 | 233 | PF04695 | 0.375 |
LIG_Pex14_2 | 225 | 229 | PF04695 | 0.513 |
LIG_SH2_CRK | 233 | 237 | PF00017 | 0.439 |
LIG_SH2_CRK | 48 | 52 | PF00017 | 0.424 |
LIG_SH2_GRB2like | 98 | 101 | PF00017 | 0.414 |
LIG_SH2_NCK_1 | 242 | 246 | PF00017 | 0.513 |
LIG_SH2_STAT5 | 242 | 245 | PF00017 | 0.436 |
LIG_SH2_STAT5 | 247 | 250 | PF00017 | 0.457 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.474 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.436 |
LIG_SH3_4 | 151 | 158 | PF00018 | 0.689 |
LIG_SxIP_EBH_1 | 162 | 175 | PF03271 | 0.541 |
LIG_TRAF2_1 | 81 | 84 | PF00917 | 0.567 |
LIG_TYR_ITIM | 231 | 236 | PF00017 | 0.375 |
MOD_CDK_SPK_2 | 245 | 250 | PF00069 | 0.436 |
MOD_CK1_1 | 150 | 156 | PF00069 | 0.695 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.690 |
MOD_CK1_1 | 65 | 71 | PF00069 | 0.568 |
MOD_GlcNHglycan | 124 | 128 | PF01048 | 0.595 |
MOD_GlcNHglycan | 152 | 155 | PF01048 | 0.707 |
MOD_GlcNHglycan | 182 | 185 | PF01048 | 0.453 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.408 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.553 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.738 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.482 |
MOD_N-GLC_1 | 36 | 41 | PF02516 | 0.466 |
MOD_N-GLC_1 | 5 | 10 | PF02516 | 0.598 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.781 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.624 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.586 |
MOD_NEK2_1 | 62 | 67 | PF00069 | 0.536 |
MOD_NEK2_2 | 154 | 159 | PF00069 | 0.689 |
MOD_NEK2_2 | 170 | 175 | PF00069 | 0.335 |
MOD_PKA_1 | 177 | 183 | PF00069 | 0.651 |
MOD_PKA_2 | 177 | 183 | PF00069 | 0.651 |
MOD_PKB_1 | 175 | 183 | PF00069 | 0.629 |
MOD_Plk_1 | 5 | 11 | PF00069 | 0.564 |
MOD_Plk_4 | 164 | 170 | PF00069 | 0.552 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.454 |
MOD_ProDKin_1 | 245 | 251 | PF00069 | 0.473 |
MOD_SUMO_for_1 | 193 | 196 | PF00179 | 0.397 |
MOD_SUMO_rev_2 | 106 | 111 | PF00179 | 0.469 |
MOD_SUMO_rev_2 | 39 | 44 | PF00179 | 0.454 |
MOD_SUMO_rev_2 | 53 | 61 | PF00179 | 0.471 |
TRG_DiLeu_BaEn_1 | 107 | 112 | PF01217 | 0.485 |
TRG_DiLeu_BaEn_1 | 30 | 35 | PF01217 | 0.468 |
TRG_DiLeu_BaLyEn_6 | 113 | 118 | PF01217 | 0.523 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.465 |
TRG_ENDOCYTIC_2 | 233 | 236 | PF00928 | 0.391 |
TRG_ENDOCYTIC_2 | 48 | 51 | PF00928 | 0.474 |
TRG_ER_diArg_1 | 174 | 177 | PF00400 | 0.397 |
TRG_ER_diArg_1 | 66 | 69 | PF00400 | 0.559 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I6B9 | Leptomonas seymouri | 56% | 100% |
A0A3S7WSF7 | Leishmania donovani | 92% | 100% |
A4H750 | Leishmania braziliensis | 70% | 99% |
A4HVJ0 | Leishmania infantum | 91% | 100% |
E9AP85 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 100% |